Overview

The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.

Eligibility

Subjects who meet the following inclusion criteria and do not meet any of the following

exclusion criteria are eligible for enrollment.

Inclusion Criteria:

        • Subject or appropriate legal guardians provide written informed consent and/or
        authorization for access to and use of health information as required by an institution's
        IRB/MEC/REB
        AND one of the following must also apply:
          -  Subject is indicated for implant or within 30 days post-implant of at least one
             Medtronic market-released product used for a pacing, sensing or defibrillation
             application
          -  Subjects who participated in a qualifying study (IDE) of a Medtronic market-released
             product with complete implant and follow-up data and subject or appropriate legal
             guardian authorizes release of subject study data
        Exclusion Criteria:
          -  Subjects who are, or will be inaccessible for follow-up
          -  Subjects with exclusion criteria required by local law (EMEA only)
          -  Subjects receiving an implant of a Medtronic device at a non-participating center and
             the implant data and current status cannot be confirmed within 30 days after implant
          -  Subjects implanted with a Medtronic device whose predetermined enrollment limit for
             that specific product has been exceeded